Role of clinical judgement in offering adjuvant chemotherapy for Breast Cancer patients in conjunction with tumour profiling test - Oncotype Dx: a single breast unit experience

被引:0
|
作者
Patnam, Varun [1 ]
Pushdary, Kamal [1 ]
Leaver, Nick [1 ]
机构
[1] Whiston Hosp, Prescot, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
WSP 17.6
引用
收藏
页码:59 / 59
页数:1
相关论文
共 50 条
  • [1] Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria
    Zekri, Jamal
    Al-Foheidi, Meteb
    Alata, Maaz
    Zabani, Reem
    Rasmy, Ayman
    BREAST CARE, 2020, 15 (06) : 642 - 647
  • [2] Decisions on adjuvant chemotherapy for patients with breast cancer based on clinical and evolving Oncotype DX criteria.
    Zekri, Jamal
    Al-Foheidi, Meteb Owaish
    Alata, Maaz Kamal
    Rasmy, Ayman Ahamd
    Rasool, Haleem J.
    Abdelrahman, Hossam A.
    Hussain, Adnan
    Sorour, Yasser
    Mashhour, Miral
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] The effect of Oncotype DX® on adjuvant chemotherapy treatment decisions in early breast cancer
    Rabie, M. A.
    Rankin, A.
    Burger, A.
    Youssef, M. M. G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (08) : 596 - 601
  • [4] Impact of Oncotype DX Recurrence Score on Adjuvant Chemotherapy Recommendations in Young Patients with Breast Cancer
    Dodman, Keisha G.
    Williams, Austin D.
    De La Cruz, Lucy M.
    Tchou, Julia C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E6 - E6
  • [5] Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
    Megan C. Roberts
    Morris Weinberger
    Stacie B. Dusetzina
    Michaela A. Dinan
    Katherine E. Reeder-Hayes
    Melissa A. Troester
    Lisa A. Carey
    Stephanie B. Wheeler
    Breast Cancer Research and Treatment, 2015, 153 : 191 - 200
  • [6] Oncotype DX Testing for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer Management
    Rabie, M.
    Rankin, A.
    Youssef, M.
    Burger, A.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 145 - 145
  • [7] Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
    Roberts, Megan C.
    Weinberger, Morris
    Dusetzina, Stacie B.
    Dinan, Michaela A.
    Reeder-Hayes, Katherine E.
    Troester, Melissa A.
    Carey, Lisa A.
    Wheeler, Stephanie B.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 191 - 200
  • [8] A comparison of oncotype DX and NHS predict to assess the benefit of adjuvant chemotherapy in patients with early breast cancer
    Deshmane, Vinay
    Raniwala, Anuja
    CANCER RESEARCH, 2021, 81 (04)
  • [9] The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting
    Choi, Joseph Do Woong
    Hughes, T. Michael D.
    Marx, Gavin
    Boyages, John
    Rutovitz, Josie
    Hasovits, Csilla
    Parasyn, Andrew
    Edirimanne, Senarath
    Ngui, Nicholas K.
    BREAST JOURNAL, 2022, 2022 : 1199245
  • [10] Factors associated with chemotherapy benefit in breast cancer patients with midrange Oncotype DX breast recurrence scores
    Cheng, Ran
    Wang, Zhongzhao
    Kong, Xiangyi
    Wang, Jing
    Fang, Yi
    Qi, Liqiang
    CANCER LETTERS, 2021, 503 : 213 - 219